# FDA recall D-1496-2020

> **Taro Pharmaceuticals U.S.A., Inc.** · Class III · drug recall initiated 2020-07-20.

## Product

Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15;  b) 45 g tube, NDC: 60429-902-45, Rx Only, For External Use Only, Not for Ophthalmic Use, Mfd by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Marketed by: Golden State Medical Supply, Inc. Camarillo, CA 93012.

## Reason for recall

Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.

## Distribution

Nationwide in the U.S.

## Key facts

- **Recall number:** D-1496-2020
- **Recalling firm:** Taro Pharmaceuticals U.S.A., Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-07-20
- **Report date:** 2020-08-19
- **Termination date:** 2023-06-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Hawthorne, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1496-2020

## Citation

> AI Analytics. FDA recall D-1496-2020. Retrieved 2026-07-06 from https://api.ai-analytics.org/recall/D-1496-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*